Medicared For All Logo

Mendel Warshawsky MD in Inwood, New York

Home New York Inwood

Mendel Warshawsky MD has Hematology/oncology as his primary medical specialty. Their primary office is: 270 Doughty Blvd in Inwood, New York. They attended Sorry, his university is not listed and graduated in 1999 (around 25 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Mendel M Warshawsky MD Office Phone and Directions

Mendel Warshawsky MD
270 Doughty Blvd
Inwood, New York 11096
516-569-0700


Patient Ratings
Please rate your experience with Mendel Warshawsky MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 516-569-0700


Enter a starting address:


Healthcare Info for Mendel Warshawsky MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1999
The Primary Medical Specialty for Mendel Warshawsky MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 25
PAC (PECOS ID)#: 7416856166
NPI #: 1699784215
NPI Created On: 08/05/2006
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 207RX0202X
License Number:
229236
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Complete blood cell count (red cells, white blood cell, platelets), automated test
  3. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  4. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  5. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  6. Infusion of chemotherapy into a vein up to 1 hour
  7. New patient office or other outpatient visit, typically 60 minutes
  8. Established patient office or other outpatient visit, typically 10 minutes
  9. Established patient office or other outpatient visit, typically 15 minutes
  10. Established patient office or other outpatient, visit typically 25 minutes
  11. Injection, dexamethasone sodium phosphate, 1 mg
  12. Injection, diphenhydramine hcl, up to 50 mg
  13. Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $30

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 799854011

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: ONCOLOGY

Name of Drug #1: FOUNDATIONONE

Drug or Biological: Device

Product Category #2: ONCOLOGY

Name Of Drug #2:: FOUNDATIONONE HEME

Drug or Biological #3:: Device

Product Category #3: ONCOLOGY

Name of Drug: FOUNDATIONONE CDX

Drug or Biological: Device

Product Category #4: ONCOLOGY

Name of Drug #4: FOUNDATIONFOCUS

Drug or Biological #4:: Device

Product Category #5: ONCOLOGY

Name of Drug #5: FOUNDATIONONE LIQUID CDX


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 799854015

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: ONCOLOGY

Name of Drug #1: FOUNDATIONONE

Drug or Biological: Device

Product Category #2: ONCOLOGY

Name Of Drug #2:: FOUNDATIONONE HEME

Drug or Biological #3:: Device

Product Category #3: ONCOLOGY

Name of Drug: FOUNDATIONONE CDX

Drug or Biological: Device

Product Category #4: ONCOLOGY

Name of Drug #4: FOUNDATIONFOCUS

Drug or Biological #4:: Device

Product Category #5: ONCOLOGY

Name of Drug #5: FOUNDATIONONE LIQUID CDX


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 799854019

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: ONCOLOGY

Name of Drug #1: FOUNDATIONONE

Drug or Biological: Device

Product Category #2: ONCOLOGY

Name Of Drug #2:: FOUNDATIONONE HEME

Drug or Biological #3:: Device

Product Category #3: ONCOLOGY

Name of Drug: FOUNDATIONONE CDX

Drug or Biological: Device

Product Category #4: ONCOLOGY

Name of Drug #4: FOUNDATIONFOCUS

Drug or Biological #4:: Device

Product Category #5: ONCOLOGY

Name of Drug #5: FOUNDATIONONE LIQUID CDX


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818588401

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818611343

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818660069

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818669707

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54


Payments Total: $16

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783475127

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $22

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783475129

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $9

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813351733

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15


Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry